Seegene showcases HPV genotyping solution at EUROGIN 2025 amid stock surge

Pallavi Madhiraju- March 20, 2025 0

Discover how Seegene’s HPV genotyping solution unveiled at EUROGIN 2025 is advancing cervical cancer screening and impacting global diagnostics. Read More

Understanding cervical cancer: Causes, symptoms, diagnosis, and prevention

pharmanewsdaily- February 9, 2025 0

Cervical cancer remains one of the most prevalent cancers affecting women worldwide, particularly those aged 45 to 65. Despite its widespread occurrence, cervical cancer is ... Read More

Genmab, Pfizer’s tisotumab vedotin takes a leap towards EU approval for cervical cancer

Pallavi Madhiraju- February 5, 2024 0

In a significant development for cervical cancer treatment, Genmab A/S (Nasdaq: GMAB) and Pfizer, Inc. (NYSE: PFE) have announced the European Medicines Agency's (EMA) validation ... Read More

Model turned reality TV star Poonam Pandey passes away, leaving a legacy shrouded in mystery

Pallavi Madhiraju- February 3, 2024 0

In an announcement that has sent shockwaves across the entertainment landscape, Poonam Pandey, the model turned reality TV star, has succumbed to cervical cancer, as ... Read More

FDA approves Merck’s KEYTRUDA for advanced cervical cancer treatment

Pallavi Madhiraju- January 14, 2024 0

Merck, known as MSD outside of the United States and Canada, has received approval from the U.S. Food and Drug Administration (FDA) for KEYTRUDA, its ... Read More

Regeneron gets Libtayo approval in Japan for advanced cervical cancer

Raghuram Kadari- December 31, 2022 0

Regeneron Pharmaceuticals has secured the approval of the Japanese Ministry of Health, Labor and Welfare (MHLW) to manufacture and market the company’s Libtayo (cemiplimab) for ... Read More

Roche cobas HPV test for cervical screening gets FDA nod for use on cobas 6800/8800 Systems

pharmanewsdaily- April 25, 2020 0

Swiss healthcare company Roche has bagged approval from the US Food and Drug Administration to use its cobas HPV test on the fully automated cobas ... Read More

FDA removes clinical hold on Advaxis’ Axalimogene Filolisbac, Durvalumab combo trial

pharmanewsdaily- July 15, 2018 0

Advaxis, a biotech firm based in New Jersey, announced a significant regulatory update as the U.S. Food and Drug Administration (FDA) has lifted the clinical ... Read More